United States· US:0093-5002_a035edd9-948f-4168-b74b-9961a2cb219a
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
A medicinal product containing olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide, registered in United States by Teva Pharmaceuticals USA, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11009350025630 TABLET, FILM COATED in 1 BOTTLE (0093-5002-56)
- ndc110093-5002-56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSINTONYN COMBIMenarini International Operations Luxembourg S.A., Luxembourg
- GermanyOlmeamlo HctTad Pharma Gmbh
- IrelandKonverge Plus 20 mg/5 mg/12.5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
- FinlandAlea CompMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Amelior Plus Hct
- Belgium · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
- Bulgaria · Олмезид Трио, Олместа А Плюс
- Cyprus · Olmedipin Plus, Orizal Plus
- Czechia · Sintonyn Combi
- Germany · Olmeamlo Hct, Olmeamlodipinhct Puren
- Estonia · Gaduar, Olmesartan Medoxomil/Amlodipine/Hct Accord
- Spain · Albis Plus, Balzak Plus
- United Kingdom (Northern Ireland) · Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm, Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm Limited
- Greece · Comprelan Plus, Gaduar
- Croatia · Omelia
- Hungary · Duactan Hct
- Ireland · Konverge Plus, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
- Italy · Gaduar, Olmesartan, Amlodipina E Idroclorotiazide Eg
- Lithuania · Gaduar, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
- Luxembourg · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
- Latvia · Gaduar, Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide Accord
- Malta · Konverge Plus
- Netherlands · Belfor Hct, Capenon Hct
- Poland · Amolisa Hct, Elestar Hct
- Portugal · Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Alter, Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Generis
- Romania · Inovum Hct, Sevikar Hct
- Slovenia · Olectan Hct, Olsitri
- Slovakia · Folgan Hct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d142a8c0-5388-45ff-97f7-98dd7fb9dee1 GET /v1/drugs/d142a8c0-5388-45ff-97f7-98dd7fb9dee1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40; 10; 25",
"substance": "OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE",
"productndc": "0093-5002",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1",
"application_number": "ANDA202491",
"marketing_category": "ANDA"
}See everything about olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.